The Food and Drug Administration approved Mirum Pharmaceuticals' Ctexli to treat Cerebrotendinous Xanthoma, a very rare lipid-storage disease. The approval makes Ctexli, or chenopod, the first ...

Federal regulators say shortages of Ozempic and Wegovy have been resolved, as supplies of popular diabetes and obesity treatments continue to improve.

Nutriband Inc. (NASDAQ: NTRB) (NASDAQ:NTRBW), a developer of transdermal pharmaceutical products, today announced that it received the Certificate of Registration from the United States Patent and ...

Discover how Grail Inc. achieved 45% revenue growth, improved scalability with the updated Galleri test, and navigates legislative and market challenges.

More than three dozen attorneys general are urging the FDA to take “decisive action” against counterfeit obesity drugs.

The UP BEd JEE 2025 registration will begin on February 15, 2025, and close on March 15, 2025. Bundelkhand University, Jhansi, will conduct the state-level exam for admission into B.Ed courses ...

A Denali Therapeutics drug for the rare enzyme deficiency Hunter ... Meanwhile, Regenxbio is gearing up to bring Hunter syndrome patients the option of a one-time treatment. The company’s ...

You have full access to this article via your institution. Figure 1: Density of actively recruiting clinical sites of biopharmaceutical clinical trials worldwide. Assessing the regional ...

who has no financial ties to the new drug. “That opens up the door to a second generation of even more effective [medications].” Suzetrigine is a pill that’s given in two dosages.

Officers, acting undercover, corresponded with the woman, agreed on a price, and set up a meeting at a Clemens ... a felony warrant for a sex offender registration violation.

Democratic senators are expressing alarm about planned budget reallocations at the Food and Drug Administration that they fear will threaten the nation’s food safety system. In a letter to FDA ...